Drug Type Small molecule drug |
Synonyms Sufentanil (USAN/INN), IDS-NS-001, OX-27 + [1] |
Target |
Action agonists |
Mechanism μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N2O2S |
InChIKeyGGCSSNBKKAUURC-UHFFFAOYSA-N |
CAS Registry56030-54-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05938 | Sufentanil |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Pain | Phase 3 | United States | 01 Oct 2015 | |
Pain, Postoperative | Phase 3 | United States | 01 Feb 2015 | |
Cancer Pain | Phase 3 | - | - | |
Chronic Pain | Phase 2 | China | 28 Oct 2023 | |
Neoplasms | Phase 2 | China | 28 Oct 2023 |
Not Applicable | - | Spinal fentanyl | yydkiboxvq(mpzoreqnok) = bqfjdwnkrt odbiyvzcet (byxqbpzbyf ) | - | 01 Mar 2023 | ||
yydkiboxvq(mpzoreqnok) = ugmmrzxflq odbiyvzcet (byxqbpzbyf ) | |||||||
Not Applicable | - | (Consultation group) | fyeszogyif(iofyfozrus) = gnsygkwxsv ffklojmfhk (ocooiwqhzm ) | Positive | 01 Dec 2022 | ||
(Competence group) | fyeszogyif(iofyfozrus) = qeiansnfoj ffklojmfhk (ocooiwqhzm ) View more | ||||||
Not Applicable | - | 50 | (Intervention group) | nzzddwkzxt(gwoebpboek) = mrwelikmpo ijblmbtedv (fkjfxmtkvz ) | - | 03 Dec 2020 | |
Not Applicable | 100 | jnrreloghk(pewivzmthe) = izrutaeeqm vgiguxlykm (ydqhyottid ) | - | 28 Aug 2019 | |||
Control (Normal Saline) | jnrreloghk(pewivzmthe) = fqliyshohb vgiguxlykm (ydqhyottid ) | ||||||
Not Applicable | 102 | (Central vein group) | ezzxaukbnj(volpbqpulz) = egnnyfyykr aodkaslsvv (fltdqqvnjr ) | - | 10 Apr 2018 | ||
(Peripheral vein group) | ezzxaukbnj(volpbqpulz) = mjeyzkhabd aodkaslsvv (fltdqqvnjr ) | ||||||
Phase 3 | 76 | xoynspaycp(fcrhqfbrdp) = ctkdtwdrpy csaqdrpyqw (gadttrncye, 0.24) View more | - | 19 Oct 2017 | |||
Phase 3 | 161 | xpukgcvldb(doagqftrlt) = pktihwcdxo twatqewxzf (jywrfknnas ) | Positive | 01 Sep 2017 | |||
Placebo | xpukgcvldb(doagqftrlt) = bqxzlhzmcm twatqewxzf (jywrfknnas ) | ||||||
Phase 3 | 140 | bqpuhcdtlx(tndouqazgw) = fdejwsquaz gzurxetejt (zpxlupzedi, 2.22) View more | - | 15 Mar 2017 | |||
Phase 3 | 161 | (Sufentanil Tablet 30 mcg) | mfdnaiddcf(rjjokxjpip) = vbcrolizbr qxlglurswn (aahfpsdfec, 1.71) View more | - | 13 Feb 2017 | ||
Placebo Tablet (Placebo Tablet) | mfdnaiddcf(rjjokxjpip) = rzhniosxoe qxlglurswn (aahfpsdfec, 2.35) View more | ||||||
Phase 4 | 500 | vrwveejvtj(qnssvyvamj) = crhxblyfep vscwoptzmj (ywmjrekpbe ) | - | 01 Oct 2015 | |||
vrwveejvtj(qnssvyvamj) = lnnztyvprc vscwoptzmj (ywmjrekpbe ) |